A Phase I dose-escalation trial, conducted at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and multiple sites nationwide, has shown that a new gene therapy treatment for high-grade gliomas — the most aggressive brain tumors — is safe and improves patient survival. Having passed this milestone, the treatment will move on to more advanced trials.
Renal Pathology ServiceMore info
40th REVIEW AND ADVANCES IN PATHOLOGYMore info
Among the Nation’s BestLearn More
Dedicated to Providing Quality Patient CareLearn More
Providing the Highest Quality EducationLearn More
Continuing an upward trend, the University of Miami Miller School of Medicine reached a record-breaking fundraising total for the fiscal year 2016. According to standards set by the Council for Advancement and Support of Education (CASE), the Miller School raised an unprecedented $159.8 million for the fiscal year, which ended May 31.
A new study led and co-authored by a University of Miami Miller School of Medicine researcher is helping to build the foundation for standardized analysis of nephrotic syndrome, a kidney disorder caused by damage to the small blood vessels that filter waste and excess water from the blood.